nad has been researched along with Alzheimer Disease in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (3.57) | 18.2507 |
| 2000's | 12 (21.43) | 29.6817 |
| 2010's | 24 (42.86) | 24.3611 |
| 2020's | 18 (32.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bormann, MK; Cohen, BM; Healy, RA; Lee, Y; Ryu, WI; Shen, M; Sonntag, KC | 1 |
| Chan, ACY; Chen, MH; Herrmann, N; Krance, SH; Kwong, S; Lanctôt, KL; Ouk, M; Song, BX; Stanley, M; Swardfager, W; Wu, CY; Xiong, LY; Yung, A; Zhang, J | 1 |
| Fathi, M; Hajibeygi, R; Jazi, K; Klegeris, A; McElhinney, A; Sayehmiri, F; Shool, S; Sodeifian, F; Tavasol, A; Tavirani, MR; Vakili, K; Yaghoobpoor, S | 1 |
| Archa Rajagopal, J; Chase Barton, C; Davis Sanders, O; Lopez, K; Lopez, O; Malik, F; Rajagopal, L | 1 |
| Bragin, DE; Bragina, OA; Kameneva, MV; Nemoto, EM; Sillerud, LO | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Boufidou, F; Constantinides, VC; Kapaki, E; Karavasilis, E; Paraskevas, GP; Pyrgelis, ES; Stefanis, L; Tentolouris-Piperas, V; Toulas, P; Velonakis, G | 1 |
| Mahley, RW | 1 |
| Cartas-Cejudo, P; Fernández-Irigoyen, J; Ferrer, I; Lachén-Montes, M; Santamaría, E | 1 |
| Abramowicz, M; Blouin, JL; Cattaneo, A; Coppola, L; Festari, C; Frisoni, GB; Lopizzo, N; Luongo, D; Marizzoni, M; Mazzelli, M; Mirabelli, P; Mombelli, E; Naviglio, D; Pievani, M; Salvatore, M | 1 |
| Chen, C; Hu, Y; Huang, X; Shen, D; Xing, S | 1 |
| Aman, Y; Bergersen, LH; Bohr, VA; Fang, EF; Frank, J; Lautrup, SH; Matysek, A; Nilsen, H; Niu, Z; Rasmussen, LJ; Shi, L; Storm-Mathisen, J; Yang, G | 1 |
| Mattson, MP | 1 |
| Xia, J; Xu, B; Zhao, N | 1 |
| Chatton, JY; Gallart-Ayala, H; Ivanisevic, J; Maillard, V; Rosenberg, N; Teav, T; van der Velpen, V | 1 |
| Chen, Z; Liang, Y; Tanzi, RE; Wang, C; Wey, HY; Xu, Y; Zhang, C | 1 |
| Hosseini, L; Mahmoudi, J; Pashazadeh, F; Sadigh-Eteghad, S; Salehi-Pourmehr, H | 1 |
| Celardo, I; Fedele, G; Loh, SHY; Martins, LM; Yu, Y | 1 |
| Behrens, MI; Bruna, BA; Gómez-Virgilio, L; Luarte, A; Ponce, DP | 1 |
| Alfano, R; Budansky, Y; Das, B; Rodriguez-Contreras, A; Shi, L | 1 |
| Alfano, RR; Harvey, G; Harvey, T; Lu, L; Rodríguez-Contreras, A; Shi, L | 1 |
| Qian, F; Ruan, J; Ruan, Q; Yu, Z; Zhang, W | 1 |
| Bohr, VA; Croteau, DL; Demarest, TG; Fang, EF; Hou, Y; Lautrup, S; Mattson, MP | 1 |
| Auwerx, J; Beck, JS; Counts, SE; D'Amico, D; Mouchiroud, L; Moullan, N; Potenza, F; Rietsch, S; Romani, M; Schmid, AW; Sorrentino, V; Zhang, H | 1 |
| Braidy, N; Grant, R; Sachdev, PS | 1 |
| Chowdhury, S; Haque, S; Mehedi, I; Nahid, NA; Poddar, SK; Sifat, AE | 1 |
| Brewer, GJ; Digman, MA; Dong, Y | 1 |
| Fang, EF | 1 |
| Li, S; Nielsen, M; Shi, J; Yin, J | 1 |
| Brewer, GJ; Dong, Y | 1 |
| Brewer, GJ; Digman, MA; Dong, Y; Sameni, S | 1 |
| Brewer, GJ; Ghosh, D; LeVault, KR | 1 |
| Chi, Y; Sauve, AA | 1 |
| Fishman, PS; Kristian, T; Long, AN; Owens, K; Schlappal, AE; Schuh, RA | 1 |
| Hoth, JJ; Liu, T; McCall, CE; Vachharajani, VT; Wang, X; Yoza, BK | 1 |
| Aitken, L; Gunn-Moore, FJ; Penedo, JC; Perez-Gonzalez, C; Quinn, SD; Samuel, ID | 1 |
| Hu, X; Sakurai, T; Takata, T; Wang, X; Yang, Y | 1 |
| Correani, V; d'Erme, M; Fontana, M; Forte, E; Fuso, A; Maras, B; Martire, S; Mosca, L; Scarpa, S | 1 |
| Adams, JD | 1 |
| Fivecoat, H; Ho, L; Ling, E; Pan, Y; Pasinetti, GM; Wang, J | 1 |
| Aljada, A; Dong, L; Mousa, SA | 1 |
| Abeti, R; Abramov, AY; Duchen, MR | 1 |
| Barnett, AJ; Brewer, GJ; Ghosh, D; LeVault, KR | 1 |
| Büchner, M; Huber, R; Riepe, MW; Staufenbiel, M; Sturchler-Pierrat, C | 1 |
| Mazzola, JL; Sirover, MA | 1 |
| Christie, R; Hyman, BT; Nikitin, AY; Webb, WW; Williams, RM; Zipfel, WR | 1 |
| Butterfield, DA; Pocernich, CB | 1 |
| Arancio, O; Caspersen, C; Chaney, M; Chen, X; Cirilli, M; Gunn-Moore, F; Kuppusamy, P; Lin, C; Liu, S; Lue, LF; Lustbader, JW; Pollak, S; Stern, D; Takuma, K; Trinchese, F; Walker, DG; Wang, N; Wu, H; Xu, HW; Yan, SS; Zewier, ZL | 1 |
| Demarin, V; Kay, G; Podobnik, SS; Storga-Tomic, D | 1 |
| Abreo, MA; Agree, CS; Aust, RM; Kissinger, CR; Li, B; Margosiak, S; Meng, JJ; Pelletier, LA; Rejto, PA; Showalter, RE; Tempczyk-Russell, A; Thomson, JA; Vanderpool, D; Villafranca, JE | 1 |
| Adès, D; Garnier-Suillerot, A; Le Moyec, L; Migonney, V; Saengkhae, C; Salerno, M; Siove, A | 1 |
| Dmitriev, LF | 1 |
| Ohm, TG; Schägger, H | 1 |
| Haushofer, M; Jellinger, KA; Kraxberger, E; Mucke, HA; Rainer, M | 1 |
| He, XY; Lin, D; Mehta, P; Merz, G; Schulz, H; Wen, GY; Yang, SY; Yang, YZ | 1 |
| Claassen, D; Martinez, AJ; Moossy, J; Rao, GR; Zubenko, GS | 1 |
18 review(s) available for nad and Alzheimer Disease
| Article | Year |
|---|---|
Endosomal-Lysosomal and Autophagy Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Topics: Alzheimer Disease; Autophagy; Biomarkers; Endosomes; Humans; Lysosomes; NAD | 2022 |
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Topics: 3-Hydroxyanthranilic Acid; Adenosine; Alzheimer Disease; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; NAD; Niacinamide; Parkinson Disease; Tryptophan | 2022 |
Does oxidative DNA damage trigger histotoxic hypoxia via PARP1/AMP-driven mitochondrial ADP depletion-induced ATP synthase inhibition in Alzheimer's disease?
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Alzheimer Disease; DNA Damage; Humans; Hypoxia; Mitochondrial Proton-Translocating ATPases; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer's disease.
Topics: Adenosine Triphosphate; Alzheimer Disease; Apolipoprotein E4; Humans; Mitochondria; NAD; Nervous System Diseases | 2023 |
Involvement of GABAergic interneuron dysfunction and neuronal network hyperexcitability in Alzheimer's disease: Amelioration by metabolic switching.
Topics: Aging; Alzheimer Disease; Animals; Diet, Ketogenic; Fasting; GABAergic Neurons; Humans; Interneurons; Ketones; NAD; Nerve Net | 2020 |
Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer's Disease: A Systematic Review of Preclinical Studies.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Apoptosis; Behavior, Animal; Disease Models, Animal; Drug Evaluation, Preclinical; Energy Metabolism; Mice; Mice, Transgenic; Mitochondria; NAD; Neuroinflammatory Diseases; Neuroprotective Agents; Niacin; Niacinamide; Oxidative Stress; Protein Aggregation, Pathological; Rats; Synapses; tau Proteins | 2021 |
Analyzing Olfactory Neuron Precursors Non-Invasively Isolated through NADH FLIM as a Potential Tool to Study Oxidative Stress in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Humans; Microscopy, Fluorescence; NAD; Olfactory Receptor Neurons; Oxidative Stress | 2021 |
Targeting NAD
Topics: Alzheimer Disease; Animals; Cognition; Flavonoids; Humans; NAD; Sirtuins | 2018 |
NAD
Topics: Aging; Alzheimer Disease; Animals; Cardiovascular Diseases; Energy Metabolism; Humans; Muscular Atrophy; NAD; Parkinson Disease | 2017 |
Nicotinamide adenine dinucleotide and its related precursors for the treatment of Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Brain; Central Nervous System; Dietary Supplements; Humans; Memory; NAD; Neuroprotective Agents; Oxidative Stress | 2018 |
Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule.
Topics: Alzheimer Disease; Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; NAD; Nicotinamide Mononucleotide; Obesity | 2019 |
Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection.
Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Energy Metabolism; Humans; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Mitochondrial Turnover; Muscle, Skeletal; NAD; Neuroprotective Agents; Niacinamide; Phosphotransferases (Alcohol Group Acceptor); Pyridinium Compounds | 2013 |
Sirtuins Link Inflammation and Metabolism.
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Cardiovascular Diseases; Energy Metabolism; Gene Expression Regulation; Homeostasis; Humans; Inflammation; Metabolic Syndrome; NAD; Oxidative Stress; Reactive Oxygen Species; Sepsis; Signal Transduction; Sirtuins | 2016 |
Alzheimer's disease, ceramide, visfatin and NAD.
Topics: Alzheimer Disease; Animals; Ceramides; Humans; NAD; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Signal Transduction | 2008 |
The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Caloric Restriction; Humans; Longevity; NAD; Resveratrol; Sirtuin 1; Stilbenes | 2010 |
Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
Topics: Alzheimer Disease; Drug Delivery Systems; Group III Histone Deacetylases; Histone Deacetylases; Humans; Longevity; Metabolic Diseases; NAD; Neurodegenerative Diseases; Saccharomyces cerevisiae; Sirtuins | 2010 |
Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer disease.
Topics: Adenosine Diphosphate; Aging; Aldehydes; alpha-Tocopherol; Alzheimer Disease; Animals; Antioxidants; Apoptosis; Cell Membrane; Energy Metabolism; Fatty Acids, Unsaturated; Humans; Lipid Peroxidation; Mitochondria; Mitochondrial ADP, ATP Translocases; Molecular Structure; NAD; Oxidation-Reduction; Reactive Oxygen Species | 2007 |
3 trial(s) available for nad and Alzheimer Disease
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Cognition; Double-Blind Method; Humans; Middle Aged; NAD; Psychiatric Status Rating Scales; Psychological Tests; Treatment Outcome | 2004 |
No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia; Dementia, Vascular; Drug Therapy, Combination; Female; Humans; Language; Male; Memory; Mental Status Schedule; Middle Aged; NAD; Orientation; Psychiatric Status Rating Scales; Psychological Tests; Treatment Failure | 2000 |
36 other study(ies) available for nad and Alzheimer Disease
| Article | Year |
|---|---|
Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease.
Topics: Alzheimer Disease; Caffeine; Energy Metabolism; Humans; NAD; Niacinamide; Pyridinium Compounds | 2022 |
Haemorheologic Enhancement of Cerebral Perfusion Improves Oxygen Supply and Reduces Aβ Plaques Deposition in a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cerebrovascular Circulation; Disease Models, Animal; Hypoxia; Mice; Mice, Transgenic; NAD; Oxygen; Perfusion; Plaque, Amyloid; Polymers | 2022 |
Hippocampal subfield volumetry in corticobasal syndrome of diverse underlying pathologies.
Topics: Alzheimer Disease; Atrophy; Corticobasal Degeneration; Hippocampus; Humans; Magnetic Resonance Imaging; NAD | 2023 |
Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory-entorhinal-amygdaloid axis in Alzheimer's and Parkinson's diseases.
Topics: Alzheimer Disease; Female; Humans; Male; NAD; Parkinson Disease; Signal Transduction; Smell | 2023 |
A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain-Gut Axis; Humans; Interleukin-10; Interleukin-6; Lipopolysaccharides; NAD; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Ribosomal, 16S; Tumor Necrosis Factor-alpha | 2023 |
Nicotinamide phosphoribosyltransferase‑related signaling pathway in early Alzheimer's disease mouse models.
Topics: Acrylamides; Alzheimer Disease; Amyloid; Animals; Behavior, Animal; Cytokines; Disease Models, Animal; Hippocampus; Learning; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAD; Nicotinamide Phosphoribosyltransferase; Piperidines; Signal Transduction; Sirtuin 1 | 2019 |
The NAD
Topics: Alzheimer Disease; Artificial Intelligence; Drug Discovery; Healthy Aging; Homeostasis; Humans; Longevity; Mitochondria; Mitophagy; NAD; Organelle Biogenesis | 2020 |
Physical exercise may exert its therapeutic influence on Alzheimer's disease through the reversal of mitochondrial dysfunction via SIRT1-FOXO1/3-PINK1-Parkin-mediated mitophagy.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Brain-Derived Neurotrophic Factor; Disease Progression; Exercise; Forkhead Box Protein O1; Humans; Mitochondria; Mitochondrial Diseases; Mitophagy; NAD; Niacinamide; Nicotinamide Mononucleotide; Protein Kinases; Pyridinium Compounds; Reactive Oxygen Species; Sirtuin 1; Ubiquitin-Protein Ligases | 2021 |
Sex-specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS.
Topics: Alzheimer Disease; Animals; Chromatography, High Pressure Liquid; Encephalitis; Female; Humans; Kynurenic Acid; Kynurenine; Male; Metabolome; Mice; Mice, Transgenic; NAD; Neuroprotection; Nicotinamide Mononucleotide; Sex Characteristics; Tandem Mass Spectrometry | 2021 |
Molecular imaging of NAD
Topics: Aging; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Mice; Mice, Transgenic; Molecular Imaging; NAD; Positron-Emission Tomography; Sirtuin 1 | 2021 |
Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Behavior, Animal; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Humans; Metabolome; Metabolomics; Mitochondria; Motor Activity; Mutation; NAD; Nerve Degeneration; Neurons; Niacinamide; Poly (ADP-Ribose) Polymerase-1; Polymorphism, Single Nucleotide | 2021 |
Alzheimer mouse brain tissue measured by time resolved fluorescence spectroscopy using single- and multi-photon excitation of label free native molecules.
Topics: Absorption, Radiation; Alzheimer Disease; Animals; Brain; Flavin-Adenine Dinucleotide; Mice; NAD; Photons; Spectrometry, Fluorescence; Time Factors | 2018 |
Label-Free Fluorescence Spectroscopy for Detecting Key Biomolecules in Brain Tissue from a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Early Diagnosis; Flavin-Adenine Dinucleotide; Humans; Mice; Mice, Transgenic; NAD; Spectrometry, Fluorescence; Tryptophan | 2017 |
Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Disease Models, Animal; Homeostasis; Humans; Male; Memory; Mice; Mice, Transgenic; Mitochondria; Mitophagy; NAD; Niacinamide; Oxidative Phosphorylation; Protein Aggregation, Pathological; Protein Biosynthesis; Proteostasis; Pyridinium Compounds; Unfolded Protein Response | 2017 |
Age- and AD-related redox state of NADH in subcellular compartments by fluorescence lifetime imaging microscopy.
Topics: Aging; Alzheimer Disease; Animals; Disease Models, Animal; Genotype; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Mitochondria; NAD; Neurons; Optical Imaging; Oxidation-Reduction; Oxidative Phosphorylation; Sex Characteristics; tau Proteins | 2019 |
Mitophagy and NAD
Topics: Alzheimer Disease; Animals; Autophagy; Cognition; Humans; Mitophagy; NAD | 2019 |
Ketones improves Apolipoprotein E4-related memory deficiency via sirtuin 3.
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Apolipoprotein E3; Disks Large Homolog 4 Protein; Hippocampus; Humans; Ketones; Learning; Maze Learning; Memory Disorders; Mice; Mice, Knockout, ApoE; NAD; Neuroprotection; Sirtuin 3; Synaptophysin | 2019 |
Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD+/NADH Redox Sites.
Topics: Aging; Alzheimer Disease; Animals; Brain; Caenorhabditis elegans Proteins; Carrier Proteins; Citric Acid Cycle; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Male; Metabolome; Mice; Mice, Transgenic; NAD; NADP; Oxidation-Reduction | 2019 |
Reversibility of Age-related Oxidized Free NADH Redox States in Alzheimer's Disease Neurons by Imposed External Cys/CySS Redox Shifts.
Topics: Aging; Alzheimer Disease; Animals; Cell Nucleus; Cells, Cultured; Cellular Senescence; Cysteine; Cystine; Cytoplasm; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Humans; Intravital Microscopy; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence; Mitochondria; NAD; Neurons; Oxidation-Reduction; Oxidative Stress; Primary Cell Culture | 2019 |
Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Glutamate-Cysteine Ligase; Glutathione; Glycyrrhetinic Acid; Mice, Inbred C57BL; Mice, Transgenic; Molecular Targeted Therapy; NAD; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Niacinamide; Oxidation-Reduction; Reactive Oxygen Species | 2014 |
Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
Topics: Alzheimer Disease; Animals; Brain; Female; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Nicotinamide Mononucleotide; Oxygen Consumption | 2015 |
Morphology-Specific Inhibition of β-Amyloid Aggregates by 17β-Hydroxysteroid Dehydrogenase Type 10.
Topics: 17-Hydroxysteroid Dehydrogenases; Alzheimer Disease; Amyloid beta-Peptides; Endosomes; Fluorescent Dyes; Humans; NAD; Peptide Fragments; Recombinant Proteins; Spectrometry, Fluorescence | 2016 |
Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Death; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory; Mitochondria; NAD; Neurons; Neuroprotective Agents; Nicotinamide Mononucleotide; Peptide Fragments; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Tissue Culture Techniques | 2016 |
Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cell Line, Tumor; CHO Cells; Citrate (si)-Synthase; Cricetulus; Disease Models, Animal; Electron Transport Complex IV; Entorhinal Cortex; Enzyme Inhibitors; Hippocampus; Lactic Acid; Membrane Potential, Mitochondrial; Mice, Transgenic; Mitochondria; NAD; Neuroprotective Agents; Peptide Fragments; Poly (ADP-Ribose) Polymerase-1 | 2016 |
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
Topics: 4-Chloro-7-nitrobenzofurazan; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Calcium; Cell Death; Coculture Techniques; Deoxyglucose; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glucose; Hippocampus; Membrane Potential, Mitochondrial; Mice; Mice, Transgenic; NAD; NADPH Oxidases; Neurons; Oxygen Consumption; Peptide Fragments; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate | 2011 |
A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons.
Topics: Adenine Nucleotides; Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Calcium; Cells, Cultured; Cerebral Cortex; Chromatography, High Pressure Liquid; Cytochromes c; Disease Models, Animal; Glutathione; Hippocampus; Humans; Hydrogen Peroxide; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; NAD; Neurons; Niacinamide; Oxidants; Oxidation-Reduction; Presenilin-1; Reactive Oxygen Species; tau Proteins; Vitamin B Complex | 2012 |
Impaired hypoxic tolerance and altered protein binding of NADH in presymptomatic APP23 transgenic mice.
Topics: Action Potentials; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Hypoxia, Brain; Ischemic Preconditioning; Male; Mice; Mice, Transgenic; NAD; Neurons; Nitro Compounds; Propionates; Protein Binding; Recovery of Function; Spectrum Analysis | 2002 |
Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts.
Topics: Age Factors; Alzheimer Disease; Blotting, Western; Cells, Cultured; Fibroblasts; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Matched-Pair Analysis; NAD; Subcellular Fractions; Time Factors | 2003 |
Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation.
Topics: Alzheimer Disease; Animals; Biophysical Phenomena; Biophysics; Collagen; Female; Fluorescent Dyes; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Microscopy, Fluorescence; NAD; Neurofibrillary Tangles; Photons; Vitamin A | 2003 |
Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease.
Topics: Acrolein; Alzheimer Disease; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Ketoglutarate Dehydrogenase Complex; Mitochondria; NAD; Pyruvate Dehydrogenase Complex; Thioctic Acid | 2003 |
ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Aged; Aged, 80 and over; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Animals; Binding Sites; Brain; Brain Chemistry; Carrier Proteins; Cells, Cultured; Cerebral Cortex; Crystallization; DNA Fragmentation; Hippocampus; Humans; Learning; Memory; Mice; Mice, Transgenic; Microscopy, Confocal; Microscopy, Immunoelectron; Mitochondria; Models, Molecular; Molecular Sequence Data; Mutation; NAD; Neurons; Protein Binding; Protein Conformation; Reactive Oxygen Species | 2004 |
Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Base Sequence; Catalytic Domain; Crystallography, X-Ray; DNA, Complementary; Drug Design; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; NAD; Protein Conformation; Protein Structure, Quaternary; Recombinant Proteins; Sequence Homology, Amino Acid | 2004 |
Ability of carbazole salts, inhibitors of Alzheimer beta-amyloid fibril formation, to cross cellular membranes.
Topics: Alzheimer Disease; Amyloid beta-Peptides; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Carbazoles; Cell Membrane; Cell Membrane Permeability; Cell Nucleus; Circular Dichroism; Cyclic P-Oxides; DNA; Glutathione; Humans; K562 Cells; Membrane Potentials; Multidrug Resistance-Associated Proteins; NAD; Nicotinic Acids; Oxidation-Reduction; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Time Factors; Triazoles | 2007 |
Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis.
Topics: Adenine Nucleotides; Aged; Aged, 80 and over; Alzheimer Disease; Electrophoresis, Gel, Two-Dimensional; Female; Hippocampus; Humans; Male; Membrane Proteins; Middle Aged; NAD; Oxidative Phosphorylation; Proton-Translocating ATPases | 1995 |
Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxyacyl CoA Dehydrogenases; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Protein Precursor; Animals; Base Sequence; Binding Sites; Cloning, Molecular; Disease Models, Animal; DNA, Complementary; Hippocampus; Humans; Mice; Mice, Transgenic; Mitochondria; Molecular Sequence Data; NAD; Presynaptic Terminals; Protein Isoforms; Protein Structure, Tertiary; Signal Transduction; Steroids; Tryptophan | 2002 |
Brain regional analysis of NADH-cytochrome C reductase activity in Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Cerebellar Cortex; Choline O-Acetyltransferase; Cytochrome Reductases; Female; Hippocampus; Humans; Male; NAD; NADH Dehydrogenase; Temporal Lobe | 1990 |